Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank100
3Y CAGR+23.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+23.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$370.19M+2.2%
2024$362.33M+69.5%
2023$213.74M+8.3%
2022$197.28M+570.0%
2021$29.44M+873.8%
2020$-3.81M-16.0%
2019$-3.28M-1046.5%
2018$-286000.00-921.4%
2017$-28000.00-27.3%
2016$-22000.00-